News

Download PDF Thynk Health’s Vice President of Strategic Partnerships & Clinical Liaison, Kim Parham, RN, BSN, CN-BN contributed to the following article in the Journal of Oncology, Navigation and Survivorship. Identifying Best Practices and Gaps in Early-Stage Lung Cancer: From Screening and Early Detection Through Resectable Disease Treatment February 2022 Vol 13, No 2 Lung […]

On November 17, 2021, the Centers for Medicare & Medicaid Services (CMS) released a proposed update to its low-dose CT lung cancer screening guideline, declaring that the evidence is sufficient to expand the eligibility criteria by lowering the age to 50 from 55 years of age (currently 55-77 years of age) and from 30 pack

Update: MedMyne changed to Thynk Health as of 10/12/2018. Medmyne is proud to have been featured in the Chattanooga Times Free Press as an innovative solution that CHI Memorial Hospital is using to detect lung cancer early.  “The ongoing debate in Washington, D.C., over the future of Obamacare may determine how many people have health